Marker Therapeutics, Inc. (MRKR)

Marker Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	13.69	19.19	15.11	11.78	42.35	21.35
Cash & Short-Term Investments	13.69	19.19	15.11	11.78	42.35	21.35
Cash Growth	20.93%	27.01%	28.26%	-72.18%	98.34%	-51.37%
Other Receivables	2.46	2.35	1.03	2.4	0	1
Receivables	2.46	2.35	1.03	2.4	0	1
Prepaid Expenses	0.84	0.48	0.99	1.85	2.48	2.06
Restricted Cash	-	-	-	-	1.15	-
Other Current Assets	-	-	-	0.59	-	-
Total Current Assets	16.99	22.02	17.13	16.62	45.98	24.41
Property, Plant & Equipment	-	-	-	-	22.15	21.2
Other Long-Term Assets	-	-	-	17.8	-	-
Total Assets	16.99	22.02	17.13	34.42	68.14	45.61
Accounts Payable	1.3	1.07	0.96	1.1	5.14	2.94
Accrued Expenses	1	2.19	1.91	1.27	3.33	2.95
Current Portion of Leases	-	-	-	-	0.62	0.39
Current Unearned Revenue	-	-	-	-	1.15	-
Other Current Liabilities	0.2	0.2	0.21	5.41	2.66	0.13
Total Current Liabilities	2.5	3.46	3.07	7.78	12.9	6.4
Long-Term Leases	-	-	-	-	11.25	11.87
Other Long-Term Liabilities	-	-	-	7.04	-	-
Total Liabilities	2.5	3.46	3.07	14.82	24.15	18.27
Common Stock	0.01	0.01	0.01	0.01	0.01	0.05
Additional Paid-In Capital	465.94	465.56	450.33	447.64	442.1	383.53
Retained Earnings	-451.46	-447.02	-436.29	-428.05	-398.12	-356.24
Shareholders' Equity	14.49	18.56	14.05	19.6	43.99	27.34
Total Liabilities & Equity	16.99	22.02	17.13	34.42	68.14	45.61
Total Debt	-	-	-	-	11.87	12.26
Net Cash (Debt)	13.69	19.19	15.11	11.78	30.48	9.1
Net Cash Growth	20.93%	27.01%	28.26%	-61.35%	235.15%	-79.05%
Net Cash Per Share	1.44	2.14	1.72	1.41	3.98	1.93
Filing Date Shares Outstanding	11.31	10.71	8.9	8.8	8.31	5.07
Total Common Shares Outstanding	11.21	10.71	8.89	8.41	8.31	5.07
Working Capital	14.49	18.56	14.05	8.84	33.08	18.01
Book Value Per Share	1.29	1.73	1.58	2.33	5.29	5.39
Tangible Book Value	14.49	18.56	14.05	19.6	43.99	27.34
Tangible Book Value Per Share	1.29	1.73	1.58	2.33	5.29	5.39
Machinery	-	-	-	-	9.66	3.87
Construction In Progress	-	-	-	-	2.23	6.79
Leasehold Improvements	-	-	-	-	3.17	0.29

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q